Serum anti-Müllerian hormone levels in women with rheumatoid arthritis during tumor necrosis factor-α inhibitor treatment: Exploratory research.
Sakiko IsojimaYoko MiuraMayu SaitoNobuyuki YajimaYusuke MiwaTsuyoshi KasamaPublished in: Obstetric medicine (2019)
Treatment with a tumor necrosis factor-α inhibitor did not affect serum anti-Müllerian hormone levels in 12 women with rheumatoid arthritis during 54-week treatment.